Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)
NCT00593944
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Lymphocytic Leukemia
Interventions
BIOLOGICAL:
MDX-1342
Sponsor
Bristol-Myers Squibb